Company Analysis
Sign in

United Therapeutics Corporation (UTHR)

Nasdaq: UTHR · Pharmaceutical Preparations · Silver Spring, MD · filing with the SEC since 1999
Full chart Alerts Compare
Grade7.3
◀ Past 7.7● Present 7.9▶ Future 6.1
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

153 patents granted to the 10 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to United Therapeutics Corporation’s names, not what it holds today.

Patents granted
153
153 utility, 1976 to Dec 31, 2025
Granted in 2025
10
Against 10 in 2024 and 14 in 2023
Applications published
259
20 of them in 2025
Names they are printed under
10
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals22
Medical technology14
Organic fine chemistry6
Biotechnology3
Chemical engineering2
Measurement2
Other special machines1
Transport1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name10 counted
United Therapeutics Corporation its own name
US, as the owner printed on each patent
127 granted
195 published
Miromatrix Medical Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
23 published
Revivicor, Inc. a subsidiary
US, as the owner printed on each patent
13 granted
10 published
United Therapeutics Corporation its own name
named as the applicant on its applications, in US
0 granted
13 published
Miromatrix Medical Inc. a subsidiary
US, as the owner printed on each patent
8 granted
2 published
IVIVA Medical, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
7 published
Revivicor, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
6 published
IVIVA Medical, Inc. a subsidiary
US, as the owner printed on each patent
4 granted
1 published
Utasia Inc. a subsidiary
US, as the owner printed on each patent
1 granted
1 published
Lung Bioengineering Inc. a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Names not counted (4)
Unither Pharmaceuticals, LLC
Most of its patents print FR; this name counts in US. 0 granted and 8 published under it are not counted.
Unither Pharmaceuticals, LLC
Most of its patents print FR; this name counts in US. 3 granted and 2 published under it are not counted.
Unither Pharma, LLC
No country is printed for it. 0 granted and 2 published under it are not counted.
UNITED THERAPEUTICS Corp
No country is printed for it. 0 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 9, 202512,491,170Stable treprostinil prodrugsPharmaceuticalsUnited Therapeutics Corporation
Nov 4, 202512,458,015Automated bioreactor system, system for automatically implementing protocol for decellularizing organ, and waste decontamination systemMeasurementUnited Therapeutics Corporation
Sep 30, 202512,427,480Apparatus for supplementing function of endocrine glandsMedical technologyIVIVA Medical, Inc.
Aug 26, 202512,397,895Structural features of a vehicle having utility to transport high value thingsTransportUnited Therapeutics Corporation
Jul 15, 202512,358,946Method for purifying antibodiesChemical engineeringUnited Therapeutics Corporation
Jul 15, 202512,357,599Prodrugs of treprostinilPharmaceuticalsUnited Therapeutics Corporation
Jun 3, 202512,322,495Computing device for enhancing communicationsMedical technologyUtasia Inc.
May 27, 202512,310,992Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsPharmaceuticalsUnited Therapeutics Corporation
Apr 15, 202512,274,684Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsPharmaceuticalsUnited Therapeutics Corporation
Apr 1, 202512,263,275Fistula filler and deployment systemMedical technologyMiromatrix Medical Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 20, 20252025/0353587STRUCTURAL FEATURES OF A VEHICLE HAVING UTILITY TO TRANSPORT HIGH VALUE THINGSTransportUnited Therapeutics Corporation
Nov 6, 20252025/0340589PURIFYING ANTIBODIESChemical engineeringUnited Therapeutics Corporation
Nov 6, 20252025/0339463PRE-CONDITIONED EXTRACELLULAR VESICLES AND METHODS OF PRODUCTIONBiotechnologyUnited Therapeutics Corporation
Oct 2, 20252025/0302786PRODRUGS OF TREPROSTINILPharmaceuticalsUnited Therapeutics Corporation
Sep 11, 20252025/0285736COMPUTING DEVICE FOR ENHANCING COMMUNICATIONSMedical technologyUtasia Inc.
Sep 11, 20252025/0282907WATER-SOLUBLE POLYURETHANES AS SUPPORT MATERIAL AND SACRIFICIAL MATERIAL FOR 3D PRINTINGMacromolecular chemistry, polymersIVIVA Medical, Inc.
Sep 11, 20252025/0282716METHODS OF MAKING IP-RECEPTOR AGONISTSOrganic fine chemistryUnited Therapeutics Corporation
Aug 28, 20252025/0269094CONTINUOUS FIBER SUPPORT BARRIER FOR ENGINEERED VASCULAR NETWORKSMedical technologyIVIVA Medical, Inc.
Jul 17, 20252025/0228236EXTRACORPOREAL ORGAN SUPPORT SYSTEMMedical technologyMiromatrix Medical Inc.
Jun 19, 20252025/0197338SYNTHESES OF COMPOUNDS USEFUL FOR PRODUCING TREPROSTINILOrganic fine chemistryUnited Therapeutics Corporation
What it applied for, 2024 to 2025: Pharmaceuticals 12 · Organic fine chemistry 10 · Medical technology 9 · Biotechnology 3 · Measurement 1 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton UTHR · research, not advice